MAPK8 and breast cancer: Zhang et al. [66] showed that parthenolide sustains JNK activation in all the four cell lines tested (nasopharyngeal carcinoma CNE1, colorectal cancer COLO205, cervical cancer HELA, and breast cancer MDA-MB-231), and consequently inhibits the translocation and DNA binding of NF-κB.